Nofi Michael — SEC insider filings

SEC reporting owner CIK 1705477. 14 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers all 14 filings on record, filed 2021-01-11 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Edgewise Therapeutics, Inc. (EWTX)Chief Financial Officer4—1 leg · 4,442 sh · $201,7877
SpringWorks Therapeutics, Inc. (SWTX)Chief Accounting Officer10——26

Insider filings — Nofi Michael

FiledFormIssuerReported transactionsSource
2026-11-104Edgewise Therapeutics, Inc. (EWTX)Option exercise (M): 10,937 @ $0 · Sale (S): 4,442 @ $45.43 · Option exercise (M): 10,937 (derivative) @ $0EDGAR
2026-08-174/AEdgewise Therapeutics, Inc. (EWTX)Grant/award (A): 48,750 (derivative) @ $0EDGAR
2026-08-144Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 24,375 (derivative) @ $0 · Grant/award (A): 48,750 (derivative) @ $0EDGAR
2025-11-134Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 43,750 (derivative) @ $0 · Grant/award (A): 262,500 (derivative) @ $0EDGAR
2025-07-024SpringWorks Therapeutics, Inc. (SWTX)Disposition to issuer (D): 30,623 · Disposition to issuer (D): 8,661 (derivative) · Disposition to issuer (D): 78,300 (derivative) · Disposition to issuer (D): 65,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,246 (derivative)EDGAR
2025-01-144SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 6,929 @ $0 · Grant/award (A): 20,246 (derivative) @ $0EDGAR
2025-01-074SpringWorks Therapeutics, Inc. (SWTX)Tax withholding (F): 2,388 @ $38.19 · Tax withholding (F): 1,636 @ $38.19 · Tax withholding (F): 1,009 @ $38.86EDGAR
2024-01-084SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 14,104 @ $0 · Tax withholding (F): 1,169 @ $37.96 · Tax withholding (F): 1,063 @ $41.53 · Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-01-104SpringWorks Therapeutics, Inc. (SWTX)Tax withholding (F): 409 @ $26.41EDGAR
2023-01-094SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 9,713 · Tax withholding (F): 783 @ $27.52 · Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0EDGAR
2022-01-144/ASpringWorks Therapeutics, Inc. (SWTX)Tax withholding (F): 414 @ $56.06EDGAR
2022-01-114SpringWorks Therapeutics, Inc. (SWTX)Tax withholding (F): 567 @ $56.06EDGAR
2022-01-104SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 5,748 · Grant/award (A): 17,913 (derivative) @ $0EDGAR
2021-01-114SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 3,000 @ $0 · Grant/award (A): 24,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1705477 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs